Horowitz Limited Partnership VIII (0001827839)

State location: CA | State of Inc.: CA | Fiscal Year End: 1231 Business Address 5030 CAMPUS DRIVE, SUITE A NEWPORT BEACH CA 92660 (949) 831-5158 Mailing Address 5030 CAMPUS DRIVE, SUITE A NEWPORT BEACH CA 92660 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner Tarsus Pharmaceuticals, Inc. 0001819790 2020-10-15 10 percent owner

Items 1 - 17

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
A	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	P-Purchase	--D	168750.0000	1920933.0000	4	0001819790	Common Stock
D	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	C-Conversion	--I	7396.0000	0.0000	12	0001819790	Series B Preferred Stock
D	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	C-Conversion	--I	43151.0000	0.0000	11	0001819790	Series A Preferred Stock
D	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	C-Conversion	--D	71427.0000	0.0000	10	0001819790	Series C Preferred Stock
D	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	C-Conversion	--D	245966.0000	0.0000	9	0001819790	Series B Preferred Stock
D	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	C-Conversion	--D	1434790.0000	0.0000	8	0001819790	Series A Preferred Stock
A	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	P-Purchase	--I	15625.0000	66172.0000	7	0001819790	Common Stock
A	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	C-Conversion	--I	7396.0000	50547.0000	6	0001819790	Common Stock
A	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	C-Conversion	--I	43151.0000	43151.0000	5	0001819790	Common Stock
A	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	C-Conversion	--D	71427.0000	1752183.0000	3	0001819790	Common Stock
A	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	C-Conversion	--D	245966.0000	1680756.0000	2	0001819790	Common Stock
A	2020-10-20		Tarsus Pharmaceuticals, Inc.	4	C-Conversion	--D	1434790.0000	1434790.0000	1	0001819790	Common Stock
-	-		Tarsus Pharmaceuticals, Inc.	3	-	--D			1	0001819790	Series A Preferred Stock
-	-		Tarsus Pharmaceuticals, Inc.	3	-	--I			5	0001819790	Series B Preferred Stock
-	-		Tarsus Pharmaceuticals, Inc.	3	-	--I			4	0001819790	Series A Preferred Stock
-	-		Tarsus Pharmaceuticals, Inc.	3	-	--D			3	0001819790	Series C Preferred Stock
-	-		Tarsus Pharmaceuticals, Inc.	3	-	--D			2	0001819790	Series B Preferred Stock

http://www.sec.gov/cgi-bin/own-disp

---